ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ONXX Onyx Pharmaceuticals, Inc. (MM)

124.70
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Onyx Pharmaceuticals, Inc. (MM) NASDAQ:ONXX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 124.70 0 01:00:00

Onyx Pharmaceuticals to Present at Upcoming Healthcare Conferences

07/06/2004 10:00pm

PR Newswire (US)


Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Onyx Pharmaceuticals, Inc. (MM) Charts.
Onyx Pharmaceuticals to Present at Upcoming Healthcare Conferences RICHMOND, Calif., June 7 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at two investment conferences in June. Goldman Sachs Twenty Fifth Annual Global Healthcare Conference The first presentation will be at the Goldman Sachs Twenty Fifth Annual Global Healthcare Conference in Laguna Niguel, California, on Wednesday, June 9, at 4:00 p.m. Pacific Time. Interested parties may access a live webcast of the presentation by clicking on the link below: http://customer.talkpoint.com/GOLD006/060704a_mk/default.asp?entity=onyx Needham & Company Third Annual Biotechnology ConferenceSubsequently, Onyx will present at the Needham & Company Third Annual Biotechnology Conference in New York City on Thursday, June 17, at 9:00 a.m. Eastern Time. Interested parties may access a live webcast of the presentation at: http://www.wsw.com/webcast/needham8/onxx/ It is recommended that viewers log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during either of the live webcasts, a recorded replay of the presentations will be available within 24 hours of the completion of the presentations. The replays will remain available for one month following the presentation dates. Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including BAY 43-9006 with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at http://www.onyx-pharm.com/. DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Julianna Wood, +1-510-262-8757, for Onyx Pharmaceuticals, Inc. Web site: http://www.onyx-pharm.com/

Copyright

1 Year Onyx Pharmaceuticals, Inc. (MM) Chart

1 Year Onyx Pharmaceuticals, Inc. (MM) Chart

1 Month Onyx Pharmaceuticals, Inc. (MM) Chart

1 Month Onyx Pharmaceuticals, Inc. (MM) Chart